Ac-LEHD-AMC is a small-molecule fluorescent substrate widely used in the detection of Caspase 9 activity. This substrate contains a specific peptide sequence (LEHD), which is a targeted substrate for Caspase 9. It can be cleaved under the catalysis of Caspase 9 to release AMC (7-amino-4-methylcoumarin), producing blue fluorescence. The maximum absorption wavelength of Ac-LEHD-AMC is usually 360 nm, and the emission wavelength is 450 nm, making it very suitable for fluorescence detection. The compound usually exists in the form of a white solid or powder, and is easily soluble in DMSO and water.
Ac-LEHD-AMC is a substrate made by linking the Caspase 9 substrate peptide (LEHD) to the fluorophore AMC. Caspase 9 is a member of the cysteine-aspartic protease family and is involved in the endogenous pathway of cell apoptosis, especially playing an important role in the death receptor pathway and mitochondrial pathway. LEHD is a specific recognition sequence for Caspase 9 and can be cleaved by Caspase 9. The release of the AMC fluorophore makes this substrate an ideal tool for fluorescent detection of Caspase 9 activity.
Structural features of Ac-LEHD-AMC include:
LEHD sequence: specifically recognizes and is cleaved by Caspase 9.
AMC fluorophore: releases AMC molecules after enzymatic cleavage, generating a fluorescent signal.
Ac group: protects the N-terminus of the substrate through an acetyl group, making it more stable in cells.
Applications
Ac-LEHD-AMC is widely used in the following fields:
Caspase 9 activity detection: as a specific substrate for Caspase 9, Ac-LEHD-AMC can be used to study the role of Caspase 9 in the process of cell apoptosis.
Apoptosis research: this substrate can be used to observe the impact of different drugs or treatments on cell apoptosis, especially in cancer drug screening.
Molecular labeling and screening: in molecular biology research, Ac-LEHD-AMC can be used to screen compounds that inhibit Caspase 9 and explore their biological functions.
Future development
The future development of Ac-LEHD-AMC may involve the following aspects:
Enhancing fluorescent properties: improving the fluorescence intensity and stability of the AMC fluorophore by modifying its structure to expand its application range.
Multi-substrate selectivity: developing more substrates specifically targeting different members of the Caspase family to enable multiplex detection.
Clinical applications: with the important role of Caspase 9 in diseases, Ac-LEHD-AMC has the potential to be used as a tool for detecting cell apoptosis in clinical diagnosis.
